Plant Summary
TCMBank_ID: | TCMBANKHE008608 |
YEM_ID: | YEM-507 |
ID: | TCMBANKHE008608/YEM-507 |
植物拉丁名: |
|
功能与主治: | See Dendrobium nobile./See Dendrobium nobile. |
药用植物名: | 细茎石斛 |
药名: | 细茎石斛 |
来源: | 云南民族药物志:第三卷 |
药用部位: | stem |
使用民族: | 傈僳族/佤族/彝族/藏族 |
TCM_ID_id: | 5076 |
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN000944 | 4,4'-dihydroxy-3,3 ', 5, α'- tetramethoxybenzophenone styrene | ||||
TCMBANKIN000975 | Mao Lamphey | ||||
TCMBANKIN007252 | 4,4'-dihydroxy-3,3 ', 5-trimethoxy-,'- dicarbonyl stilbene | ||||
TCMBANKIN009132 | chrysotoxene | C18H18O5 | 314.33 | COC1=C(C(=C2C(=C1)C=CC3=C2C=CC(=C3OC)O)OC)OC | |
TCMBANKIN011595 | Trans-3,5-dihydroxy-5-methoxy-stilbene | C15H14O3 | COC1=CC(=CC(=C1)O)C=CC2=CC=C(C=C2)O | ||
TCMBANKIN017594 | 4,4 ', α'- trihydroxy-3,3', 5-trimethoxy stilbene | ||||
TCMBANKIN037409 | Dendroside F | 430.5 g/mol | |||
TCMBANKIN039426 | Dendrobiumane E | ||||
TCMBANKIN039573 | vanilloloside | vanilloloside | C14H20O8 | 316.304 | c1(OC([H])([H])[H])c([H])c(C([H])([H])O[H])c([H])c([H])c1O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2 |
TCMBANKIN041778 | Dendromoniliside A | 414.5 g/mol | |||
TCMBANKIN041831 | Dendrobiumane D | ||||
TCMBANKIN043483 | dendromoniliside b | C21H32O11 | 460.5 g/mol | CC12C(CCC1C(=O)O)C3C(C(C2OC4C(C(C(C(O4)CO)O)O)O)OC3=O)C(C)(C)O | |
TCMBANKIN044598 | 7-hydroxy-5,6-dimethoxy-1,4-phenanthrene-quinone | C16H12O5 | |||
TCMBANKIN044955 | Dendromoniliside C | 444.5 g/mol | |||
TCMBANKIN047722 | dendrobiumane b | C15H24O4 | CC(C)C1C2C3CCC(C3(C(C1OC2=O)O)C)CO | ||
TCMBANKIN048623 | dendrobiumane c | C15H22O4 | |||
TCMBANKIN049046 | dendrobiumane a | C15H26O3 | |||
TCMBANKIN049694 | 3,7-dihydroxy-2,5-diundecylnaphthoquinone | C32H50O4 | 498.7 g/mol | CCCCCCCCCCCC1=C2C(=CC(=C1)O)C(=C(C(=O)C2=O)CCCCCCCCCCC)O | |
TCMBANKIN050327 | Dendromoniliside D | 446.5 g/mol | |||
TCMBANKIN060594 | 10β,13,14-trihydroxyalloaromadendrane | C21H36O8 | CC1CCC2C1C3C(C3(C)CO)CCC2(COC4C(C(C(C(O4)CO)O)O)O)O | ||
TCMBANKIN061764 | Acanthoside B;(+)-Syringaresinol-O-beta-D-glucoside | ACon1_001107; (7alpha,7'alpha,8alpha,8'alpha)-4'-(beta-D-glucopyranosyloxy)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignan-4-ol; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenoxy]-6-methylol-tetrahydropyran-3,4,5-triol; 7374-79-0; (+)-syringaresinol beta-D-glucoside; (+)-Syringaresinol O-beta-D-glucoside; acanthoside b; C10890; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol; beta-D-Glucopyranoside, 2,6-dimethoxy-4-(tetrahydro-4-(4-hydroxy-3,5-dimethoxyphenyl)-1H,3H-furo(3,4-c)furan-1-yl)phenyl, (1S-(1alpha,3aalpha,4a,6aalpha))-; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; CHEBI:28603; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; MEGxp0_000366;(+)-syringaresinol-o-beta-d-glucopyranoside | C28H36O13 | 580.58 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC5C(C(C(C(O5)CO)O)O)O)OC |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
---|